CIK: 1778623 - Address: C/O Dianthus Therapeutics, Inc., 7 Times Square, 43Rd Floor, New York, NY 10036
12 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
11/12/21 16:15
11/9/21
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagVeness Adam MMAOSVP,GC,SM.d13229.37052423D
9/22/21 18:08
9/21/21
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagVeness Adam MMAOSVP,GC,SM.d21732.58075419D
9/22/21 18:08
9/21/21
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagVeness Adam MMAOSVP,GC,SS.d-998150.050-7-2619D
9/9/21 17:07
9/8/21
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagVeness Adam MMAOSVP,GC,SS.m-184130.000-1-719D
1/6/21 19:12
1/5/21
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagVeness Adam MMAOSVP,GC,SS-252122.560-2-1116D
9/9/20 17:49
9/8/20
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagVeness Adam MMAOSVP,GC,SS-17989.500-2-919D
4/10/20 17:30
4/8/20
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagVeness Adam MMAOSVP,GC,SM.d16827.97064021D
4/10/20 17:30
4/8/20
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagVeness Adam MMAOSVP,GC,SS.d-51485.580-6-2221D
1/3/20 21:51
1/2/20
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagVeness Adam MMAOVP,GC,SeS.m-6851.760-1-815D
9/10/19 20:25
9/10/19
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagVeness Adam MMAOVP,GC,SeS-3745.200-1-516D
8/12/19 16:18
8/9/19
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagVeness Adam MMAOVP,GC,SeS-14745.000-3-1617D
7/17/19 17:49
7/16/19
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagVeness Adam MMAOVP,GC,SeS-2240.710-1-320D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact